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Hydrogen Sulfide Maintains Mesenchymal Stem Cell Function and Bone
Homeostasis via Regulation of Ca2+ Channel Sulfhydration
Abstract
Gaseous signaling molecules such as hydrogen sulfide (H2S) are produced endogenously and mediate
effects through diverse mechanisms. H2S is one such gasotrasmitter which regulates multiple signaling
pathways in mammalian cells, and abnormal H2S metabolism has been linked to defects in bone
homeostasis. Here, we demonstrate that bone marrow mesenchymal stem cells (BMMSCs) produce H2S
to regulate their self-renewal and osteogenic differentiation, and H2S deficiency results in defects in
BMMSC differentiation. H2S deficiency causes aberrant intracellular Ca2+ influx, due to reduced
sulfhydration of cysteine residues on multiple Ca2+ TRP channels. This decreased Ca2+ flux
downregulates PKC/Erk-mediated Wnt/β-catenin signaling which controls osteogenic differentiation of
BMMSCs. Consistently, H2S-deficient mice display an osteoporotic phenotype, which can be rescued by
small molecules which release H2S. These results demonstrate H2S regulates BMMSCs, and restoring
H2S levels via non-toxic donors may provide treatments for diseases such as osteoporosis which can
arise from H2S deficiencies.
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SUMMARY
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Gaseous signaling molecules such as hydrogen sulfide (H2S) are produced endogenously and
mediate effects through diverse mechanisms. H2S is one such gasotrasmitter which regulates
multiple signaling pathways in mammalian cells, and abnormal H2S metabolism has been linked
to defects in bone homeostasis. Here, we demonstrate that bone marrow mesenchymal stem cells
(BMMSCs) produce H2S to regulate their self-renewal and osteogenic differentiation, and H2S
deficiency results in defects in BMMSC differentiation. H2S deficiency causes aberrant
intracellular Ca2+ influx, due to reduced sulfhydration of cysteine residues on multiple Ca2+ TRP
channels. This decreased Ca2+ flux downregulates PKC/Erk-mediated Wnt/β-catenin signaling
which controls osteogenic differentiation of BMMSCs. Consistently, H2S-deficient mice display
an osteoporotic phenotype, which can be rescued by small molecules which release H2S. These
results demonstrate H2S regulates BMMSCs, and restoring H2S levels via non-toxic donors may
provide treatments for diseases such as osteoporosis which can arise from H2S deficiencies.
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INTRODUCTION
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Hydrogen sulfide (H2S) is a colorless and poisonous gas with the characteristic foul odor of
rotten eggs. Recent studies showed that H2S serves as a gasotransmitter to regulate a variety
of signaling pathways (Wang, 2003). Physiologically, H2S plays an important role in the
induction of hippocampal long-term potentiation, brain development, blood pressure
regulation and inflammatory responses (Fiorucci et al., 2005; Li et al., 2006; Olson and
Donald, 2009; Yusuf et al., 2005; Zhong et al., 2003). Abnormal H2S metabolism has been
linked to several human diseases, including Alzheimer’s, hypertension, coronary heart
disease, atheroscerosis, cataracts, pancreatitis and type 1 diabetes (Donovan et al., 2011; Gil
et al., 2011; Li et al., 2005).
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In mammals, H2S is generated from L-cysteine catalyzed by two pyridoxal-5′-phosphatedependent enzymes, termed cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE)
(Bukovska et al., 1994; Erickson et al., 1990; Swaroop et al., 1992; Wang, 2002). CBS and
CSE expression has been identified in many human and other mammalian cells, including
those from liver, kidney, brain, smooth muscle, pancreas and lymphocytes (Stipanuk and
Beck, 1982; Tang et al., 2006). CBS is reported to be the predominant H2S-generating
enzyme in the brain and nervous system, and CSE is mainly expressed in the vascular
smooth muscles and pancreas (Abe and Kimura, 1996; Bao et al., 1998; Simpson and
Freedland, 1976).
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CBS deficiency is an autosomal recessive disease that is the most frequent cause of clinical
hyperhomocysteinemia and homocystinuria (Uren et al., 1978; Watanabe et al., 1995).
Patients may have multisystem disorders, including dislocated lenses, mental deficiency,
premature arteriosclerosis, thrombosis, and osteoporosis. Epidemiological and clinical
studies suggest that hyperhomocysteinemia patients have an increased risk of fracture
(Dhonukshe-Rutten et al., 2005; Gjesdal et al., 2007; McLean et al., 2004; van Meurs et al.,
2004). However, the etiology for the increased prevalence of osteoporosis in these patients
remains unclear. Although a high serum level of homocysteine (HCY) has been considered
as one of the factors causing osteoporosis in these patients, controversial reports on the
effects of high levels of HCY on osteoclasts and osteoblasts have made it difficult to
uncover the precise mechanism. In addition to elevated HCY, CBS-deficient patients also
have notable reduced H2S level. Therefore, we hypothesize that a stable, low level of H2S in
the human body may play an important role in maintaining the homeostasis of the bone/
marrow system.
Bone marrow mesenchymal stem cells (BMMSCs) are nonhematopoietic multipotent stem
cells and play an important role in maintenance of the bone/marrow homeostasis
(Friedenstein et al., 1974; Pittenger et al., 1999; Prockop, 1997). BMMSCs and BMMSCderived osteoblasts are responsible for bone formation and balancing osteoclast-mediated
bone resorption to maintain bone mineral density. It is unknown whether BMMSCs produce
H2S or if H2S levels affect BMMSC function. In this study, we show that BMMSCs express
both CBS and CSE and produce H2S. More importantly, H2S is required to maintain stem
cell properties in BMMSCs.
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RESULTS
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BMMSCs express CBS/CSE and produce H2S
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Since H2S plays important biological roles in a variety of cell types, we hypothesized that
H2S may affect BMMSC function. Interestingly, we found that both human and mouse
BMMSCs expressed CBS and CSE, as assessed by Western blot, RT-PCR, and
immunostaining (Figures 1A–1C). Double immunostaining showed that BMMSCs
coexpressed CD73, a mesenchymal stem cell marker, with CBS and CSE (Figures 1D and
1E). BMMSCs were also able to produce H2S in culture supernatant at a level of 8–10 μM,
which was upregulated by the treatment of H2S donor NaHS and downregulated by the
treatment of the CBS inhibitor hydroxylamine (HA) or the CSE inhibitor D, Lpropargylglycine (PAG) (Figure 1F and Figure S1A). However, combined treatment using
HA and PAG showed the same H2S reduction as observed in the groups that received only
HA or PAG (Figure 1F). Moreover, we revealed that mouse serum H2S levels were
upregulated by intraperitoneal (IP) injection of NaHS and downregulated by IP injection of
HA or PAG (Figure 1G). Combined injection of HA and PAG showed similar
downregulated H2S levels to ones observed in the HA or PAG groups (Figure 1G). These
data indicate that BMMSCs express both CBS and CSE, and produce H2S. H2S production
by BMMSCs is upregulated by H2S donor and downregulated by H2S inhibitor,
respectively. In addition to expressing CBS and CSE, both human and mouse BMMSCs
express 3-mercaptopyruvate sulfurtransferase (3-MST) and cysteine aminotransferase
(CAT), as shown by Western blot, RT-PCR, immunocytostaining, and flow cytometric
analysis (Figures S1B–S1F). When expression of either 3-MST or CAT was knocked down
by siRNA, H2S production by BMMSCs was partially reduced and their in vitro osteogenic
differentiation was impaired, assessed by alizarin red staining (Figures S1G–S1I).
H2S is required for maintenance of BMMSC function in vivo
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To examine whether H2S serves as a physiologic gasotransmitter to regulate stem cell
properties, we used CBS knockout mice as an H2S-deficient model to examine BMMSC
function (Watanabe et al., 1995). Previous study showed that CBS knockout mice had a
cartilage deficiency, but was not reported whether they also had osteogenic disorder
(Watanabe et al., 1995). We revealed that CBS−/− mice displayed several abnormalities,
including severe growth retardation and developmental defects (Figure S2A), which led to
death at 4 weeks of age in most cases (Watanabe et al., 1995). CBS+/− mice survived
normally, and only 1/50 mice showed the reduction in body weight and loose hair that were
observed in CBS−/− mice (Figure S2A). CBS protein was absent in CBS−/− BMMSCs and
decreased to half of normal levels in CBS+/− BMMSCs (Figure S2B). Endogenous H2S
levels in serum showed a 50% reduction in both CBS−/− and CBS+/− mice compared with
normal C57BL6 mice (Figure 2A), which may indicate production of H2S using CSE as an
alternative enzyme. Furthermore, we revealed that cultured CBS−/− and CBS+/− BMMSCs
produced similarly reduced levels of H2S (Figure 2B). All CBS−/− mice and 66.6% of
CBS+/− mice had osteopenia phenotypes, as assessed by histological analysis that showed
reduced femur trabecular bone volume (Figure 2C) and microCT analysis that showed
reduced bone mineral density (BMD) and bone volume/tissue volume (BV/TV) in femurs
(Figure 2D).
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Since it is unknown whether CBS deficiency affects BMMSCs, we next revealed that
CBS−/− and CBS+/− BMMSCs showed increased proliferation rates (Figures 2E). When
cultured under osteo-inductive conditions, CBS−/− and CBS+/− BMMSCs showed reduced
capacities for mineralized nodule formation, expression of the osteogenic makers Runtrelated transcription factor 2 (Runx2) and alkaline phosphatase (ALP), and regeneration of
new bone when implanted into immunocompromised mice subcutaneously (Figures 2F and
2G). However, when induced under adipogenic conditions, CBS−/− and CBS+/− BMMSCs
showed adipogenic differentiation capacities similar to that observed in normal BMMSCs,
as assessed by Oil red O staining to show the number of adipocytes and RT-PCR to show
expression levels of lipoprotein lipase (LPL) and peroxisome proliferator-activated receptorgamma 2 (PPARγ2) (Figure S2C).
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Interestingly, elevating H2S levels in CBS+/− BMMSCs by in vitro H2S donor NaHS
treatment was able to rescue their cell proliferation rate, capacity formineralized nodule
formation, expression of osteogenic markers Runx2 and ALP, and capacity for in vivo bone
formation (Figures 3A–3C). However, H2S donor NaHS treatment failed to affect
adipogenic differentiation in CBS+/− BMMSCs, as shown by Oil red O staining and RTPCR to show expression levels of LPL and PPARγ2 (Figure S3A). These data imply that
H2S is required for maintaining stem cell properties of BMMSCs.
H2S is required for maintenance of BMMSC function in vitro
We next used an in vitro culture system to examine the role of H2S in BMMSC proliferation
and differentiation. When treated with the CBS inhibitor HA, the CSE inhibitor PAG, CBS
siRNA or CSE siRNA to reduce H2S levels, BMMSCs showed a similar phenotype to the
one observed in CBS+/− BMMSCs, including increased proliferation rate, reduced capacity
for forming mineralized nodules in vitro, downregulation of Runx2 and ALP, and reduced
new bone formation when implanted into immunocompromised mice subcutaneously
(Figures 3D–3F). In contrast, reducing H2S levels in BMMSCs using CBS inhibitor, CSE
inhibitor or CBS siRNA treatment showed no effect on their adipogenic differentiation
(Figures S3B–S3D). These data confirm that H2S is required to maintain BMMSC selfrenewal and osteogenic differentiation.
Elevation of H2S level in CBS+/− mice rescues osteopenia phenotype and BMMSC function
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In order to examine whether H2S donor treatment rescues BMMSC function and osteopenia
phenotype in H2S-deficient mice, H2S donor GYY4317 was IP injected into CBS+/− mice
every other day at 1 mg/mouse for 28 days (total of 14 injections) (Figure 4A). After the last
injection, serum H2S levels, femur trabecular bone volume, BMD, and BV/TV were
significantly increased in CBS+/− mice (Figures 4B–4D). Additionally, BMMSCs from
GYY4317-treated CBS+/− mice showed significant rescue of cell proliferation rate, capacity
to form mineralized nodules, expression of the osteogenic markers Runx2 and ALP, and
formation of new bone in vivo when compared to the untreated CBS+/− BMMSCs (Figures
4E–4G). As expected, GYY4317 treatment failed to affect adipogenic differentiation of
CBS+/− BMMSCs, as evaluated by the number of Oil Red O-positive cells and expression
levels of LPL and PPARγ2 (Figures S4A and S4B). These results indicate that elevation of
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H2S levels by H2S donor treatment is capable of rescuing the osteopenia phenotype and
osteogenic deficiency of BMMSCs in CBS+/− mice.
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CBS inhibitor HA and CSE inhibitor PAG treatment resulted in osteopenia phenotype and
BMMSC impairment in vivo
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Next, we examined whether injection of CBS inhibitor to reduce H2S levels would cause
osteopenia phenotype and BMMSC impairment, as observed in CBS+/− mice. When CBS
inhibitor HA was IP-injected into C57BL6 mice every other day at 100 μg/mouse for 28
days (totally 14 injections), serum H2S levels and CBS protein expression levels were
significantly decreased when compared to the untreated control group (Figures 5A–5C). HA
treatment resulted in a significant reduction in femur trabecular bone area, BMD, and
BV/TV in C57BL6 mice (Figures 5D and 5E). BMMSCs derived from HA-treated mice
showed the same phenotype observed in CBS+/− BMMSCs, including increased
proliferation rate, decreased population doubling, decreased capacity to form mineralized
nodules and expression of the osteogenic makers Runx2 and ALP, as well as reduced new
bone formation in vivo (Figures 5F–5I). However, HA treatment failed to affect the
adipogenic differentiation of BMMSCs (Figure 5J). These data suggest that reduction of
H2S levels may be directly associated with BMMSC impairment and osteopenia phenotype.
Moreover, when CSE inhibitor PAG was IP injected into C57BL6 mice every other day at
100 μg/mouse for 28 days (a total of 14 injections) (Figure S5A), serum H2S levels and CSE
protein expression levels were significantly decreased when compared to the untreated
control group (Figures S5B and S5C). PAG treatment resulted in a significant reduction in
femur trabecular bone area, BMD, and BV/TV in C57BL6 mice (Figures S5D and S5E).
BMMSCs derived from PAG-treated mice showed the same phenotype observed in CBS+/−
BMMSCs, including increased proliferation rate and decreased capacity to form mineralized
nodules and expression of the osteogenic makers Runx2 and ALP, as well as reduced new
bone formation in vivo (Figures S5F–S5H).
H2S level, but not homocysteine accumulation, may contribute to BMMSC impairment in
CBS-deficient mice
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CBS deficiency-induced homocysteine accumulation may contribute to diseased phenotypes
in CBS-deficient patients (Gaustadnes et al., 2000; Kelly et al., 2003; Kluijtmans et al.,
1999; Maclean et al., 2002; Miles and Kraus, 2004). In order to clarify whether
homocysteine accumulation affects BMMSC function in CBS-deficient conditions, we
assessed plasma homocysteine levels in CBS deficient mice and found that CBS−/− mice had
34 times greater plasma homocysteine levels than age-matched C57BL6 (WT) mice.
However, CBS+/− mice, which have an osteopenia phenotype similar to CBS−/− mice,
showed plasma homocysteine levels only twice as high as age-matched C57BL6WT mice
(Figures S5I and S5J). Both CBS−/− and CBS+/− mice showed elevated numbers of tartrateresistant acid phosphatase (TRAP) positive osteoclasts in their femurs and elevated receptor
activator of nuclear factor kappa-B ligand (RANKL) levels in serum when compared to WT
control mice. CBS−/− mice, however, exhibited a more significant increase in the number of
TRAP positive osteoclasts and higher levels of RANKL than that of CBS+/− mice (Figures
S5K and S5L). These data suggest that homocysteine levels may be associated with
osteoclast activity. Although IP injection of H2S donorGYY4317 rescued the osteopenia
Cell Stem Cell. Author manuscript; available in PMC 2015 July 03.
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phenotype and BMMSC function in CBS+/− mice, it failed to reduce serum homocysteine
levels in CBS+/− mice (Figure S5M). These data suggest that H2S levels may affect the
osteopenia phenotype via regulating BMMSC differentiation in CBS-deficient mice.
Although IP injection of CBS inhibitor reduced H2S levels and resulted in an osteopenia
phenotypein C57BL6 mice (Figures 5L and 5M), only slightly elevated serum homocysteine
levels was observed (Figure S5N), confirming that H2S levels affect the osteopenia
phenotype. To determine whether homocysteine has any direct effect on BMMSCs, we used
a dose of 100–200 μM homocysteine to treat BMMSCs in vitro and found that the treatment
failed to affect cell proliferation, in vitro mineralized nodule formation, and in vivo bone
formation of BMMSCs (Figures S5)-S5Q). This experimental evidence suggests that H2S
levels, but not homocysteine, may directly affect BMMSC function. In addition, we showed
that in vitro NaHS treatment resulted in reduced numbers of osteoclasts, while
homeocysteine treatment increased osteoblast numbers (Figure S5R).
H2S deficiency causes BMMSC impairment via attenuation of Ca2+ influx

NIH-PA Author Manuscript

H2S serves as a gasotransmitter to control cellular Ca2+ levels, which, in turn, regulate cell
biological signaling (Distrutti, 2011; Li et al., 2011; Ogawa et al, 2012). We showed that
H2S donor NaHS treatment induced a concentration-dependent Ca2+influx in BMMSCs
(Figure 6A). H2S-induced Ca2+ elevation mainly resulted from Ca2+ influx with a limited
contribution from intracellular Ca2+ storage (Figure 6B). Single TRP channel knockdown by
siRNA for the TRPC subfamily (TRPC1, 3, and 7), TRPV subfamily (TRPV1 and 4) and
TRPM subfamily (TRPM2, 4, and 8) failed to block H2S-induced (NaHS 100 μM) Ca2+ in
fluxin BMMSCs (Figures S6A–S6L). No significant difference was observed in the amount
of Ca2+ influx among the different groups (Figure S6M). These data suggest that H2S may
affect not only one specific TPR Ca2+ channel, but rather multiple different TRP Ca2+
channels. Thus, we next tested the effect of combinations of siRNA knockdown of three
TRP channels (TRPV6, TRPV3, and TRPM4) that contain cysteine (Cys) residues with
potential to undergo sulfhydration. Interestingly, we found that knockdown of TRPV6,
TRPV3, and TRPM4 together blocked more than 50% of H2S-induced (NaHS 100 μM)
Ca2+ influx in BMMSCs (Figure 6C). These results indicate that H2S affects multiple TRPs
channels that may be associated with Cys residue sulfhydration.
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Sulfhydryl number in Ca2+ channels determines H2S-induced Ca2+ influx
H2S modifies specific Cys residues (–SH) in proteins through the formation of a persulfide
(– SSH) bond, and this modification has been termed protein sulfhydration. The
physiological function of sulfhydration may be involved in the regulation of inflammation
and endoplasmic reticulum stress signaling, as well as vascular tension (Krishnan et al.,
2011; Li et al., 2006). In order to further explore if H2S levels affect Ca2+ channel
sulfhydration in BMMSCs, the numbers of free Cys residues (sulfhydryl, –SH) on
cytomembrane between H2S-deficient and normal BMMSCs were compared using classical
Ellman’s reagent (Ellman, 1959). Free sulfhydryls were found in decreased numbers in
CBS+/− BMMSCs when compared to normal BMMSCs (Figure 6D). These data
demonstrate that the number of free sulfhydryls in BMMSC membranes may correlate with
H2S-induced Ca2+ influx. Next, we used chemical agent treatment to alter the number of
free sulfhydryls and measured if this treatment affected H2S-induced Ca2+ influx.
Cell Stem Cell. Author manuscript; available in PMC 2015 July 03.

Liu et al.

Page 7

NIH-PA Author Manuscript

Dithiothreitol (DTT) can reduce the disulfide bonds of proteins and increase the number of
residual sulfhydryl proteins (Cleland, 1964). In contrast, diamide (DM) is capable of
reducing the number of sulfhydryls (Kosower et al., 1969), and (2-sulfonatoethyl) methane
thiosulfonate (MTSES) is a nonpermeable reagent able to reduce free sulfhydryls only on
the outer cytomembrane (Chen et al., 1997). In comparison to the control group (Figure
S6N), DTT-treated BMMSCs showed an elevated amount of NaHS-inducedCa2+ influx
(Figure S6N). DM-treated BMMSCs showed a reduction in NaHS-inducedCa2+ influx
(Figure S6N). MTSES treatment also decreased NaHS-induced Ca2+ influx in BMMSCs,
but not as effectively as the DM treatment did (Figure S6N). Quantitative analysis
confirmed that DTT treatment elevated levels of Ca2+ influx and free sulfhydryl in
BMMSCs (Figures 6E and 6F). In contrast, DM and MTSES treatment induced reduced
levels of Ca2+ influx and free sulfhydryl in BMMSCs (Figures 6E and 6F). These results
suggest that the number of free sulfhydryls, both inside and outside of the BMMSC
cytomembrane, affects NaHS-induced Ca2+ influx. We used 1 mM of DTT, DM and
MTSES to treat BMMSCs for 15 minutes, which failed to affect cell viability (data not
shown).
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Sulfhydration (SHY) is a physiological process whereby H2S attaches an additional sulfur to
the sulfhydryl (–SH) groups of Cys yielding a hydropersulfide (–SSH) (Krishnan et al.,
2011). In order to examine whether H2S affects sulfhydration of Ca2+TRP channels, we
used amodified Alexa Fluor 488-conjugated C5 maleimide (green maleimide) assay to
detect sulfhydration. Maleimide interacts selectively with sulfhydryl groups of Cys, labeling
both sulfhydrated and unsulfhydrated Cys. An advantage of this method is that nitrosylated
or oxidized Cysdo not react with maleimide. The samples were treated with DTT, which
selectively cleaves disulfide bonds and detaches the green signal from sulfhydrated protein,
but not unsulfhydrated protein, resulting in decreased fluorescence. We employed green
maleimide to detect transient receptor potential (TRP) sulfhydration in BMMSCs with or
without H2S treatment (Figure 6G). We first selected TRPV6 as a representative TRP
protein to examine sulfhydration. The level of sulfhydration of TRPV6 was calculated based
on the residual green fluorescence intensity compared to the total amount of TRPV6 protein,
which was regulated by DTT treatment (Figure 6H). We found that without H2S treatment,
DTT did not affect the levels of “green” TRPV6 protein, indicating the absence of
sulfhydration (Figure 6H). In contrast, H2S treatment reduced the green signal in the
presence of DTT, indicating that sulfhydration had occurred in the TRPV6 protein. We
further employed mass spectrometric analysis to identify the Cys residue responsible for
sulfhydration of TRPV6 proteins in BMMSCs. We used online LC-Orbitrap MS and CID
MS/MS to confirm that H2S treatment converted SH to SSH at specific modification sites
(Figure S6O). The conversion leads to a defined mass change of the peptide from PDI
digest, which was directly measured with a high level of confidence by high-resolution MS
(Figure S6P). The mass shift suggested that BMMSCs were modified by H2S through Ssulfhydration of Cys residues. Then we used CID fragmentation MS/MS to localize the
modification sites with single amino acid resolution. Detection of precursor ions at high
resolution and a nearly complete series of fragmentation ions from CID allowed the accurate
sequencing and identification of a single site of modification. Integrating MS and CID
MS/MS results, Protein Discoverer 1.3 automatically assigned potential modification sites
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with a high level of confidence. After H2S treatment, we found that Cys residues were
sulfhydrated, with a high level of confidence, at the C172 and C329 sites (Figures S6O and
S6P). Next, we generated TRPV6C172mu and TRPV6C329mu constructs and overexpressed
TRPV6, TRPV6C172mu, TRPV6C329mu and TRPV6C172+C329mu in BMMSCs (Figure S6Q
and S6U). Overexpression of TRPV6 could slightly increase Ca2+ influx, and it activated
Ca2+ downstream signaling p-PKC and active β-catenin, along with downregulation of p-Erk
(Figures S6R and S6S). At the functional level, overexpression of TRPV6 in BMMSCs
increased in vitro osteogenic differentiation (Figure S6T). Overexpression of
TRPV6C172+C329mu, but not TRPV6C172mu or TRPV6C329mu, reduced H2S donor-induced
upregulation of p-PKC and active β-catenin and in vitro osteogenic differentiation in the
TRPV6 group (Figures S6S and S6T). These data suggest although H2S affects
sulfhydration in multiple Ca2+ channels, TRPV6 C172 and C329 contribute at least partially
to sulfhydration-controlled Ca2+ influx in BMMSCs. In addition to TRPV6, we showed that
other Ca2+ TRP channels, including TRPV3 and TRPM4, were also assigned sulfhydration
sites with a high level of confidence at Cys residues via fluorescence Western blot and CID
MS/MS (Figures S6V–S6X). These data suggest that multiple TRP Ca2+ channels are
sulfhydrated after H2S treatment.
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Reduction of H2S levels induced osteogenic deficiency in BMMSCs via Wnt/β-catenin
pathway
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In order to examine how H2S deficiency-induced reduction of Ca2+influx affects osteogenic
differentiation of BMMSCs, we analyzed three Ca2+ downstream pathways, including PCK/
Erk, PI3K/Akt/GSK3β and CaMKII/Calcineurine A cascades, which are closely linked to
Ca2+-associated regulation of osteogenic differentiation (Li et al., 2011; Lof et al., 2012).
We found that expression levels of p-PKC significantly decreased along with upregulation
of p-ErK in CBS+/− BMMSCs and H2S inhibitor-treated BMMSCs (Figure 7A). However,
expression levels of PI3K/Akt and CaMKII showed no difference between CBS+/− and
control BMMSCs (Figure S7A). Therefore, we focused on assessing PCK/Erk signaling and
confirmed that H2S inhibitor-treated BMMSCs have decreased expression of p-PCK and
elevated expression of p-Erk (Figure 7A). In contrast, H2S donor NaHS treatment induced
upregulation of p-PKC, but downregulation of p-ERK in BMMSCs (Figure 7A). NaHS
treatment failed to upregulate p-PKC expression in BMMSCs (Figure 7B). Since Erk
inhibitor treatment failed to affect p-PKC expression in BMMSCs (Figure 7C), Erkmight be
downstream of the PKC pathway. Taken together, these data indicate that H2S-regulated
Ca2+ influx affects p-PKC and p-Erk expression in BMMSCs.
Since PKC phosphorylation can serve as part of the Wnt/calcium pathway, which regulates
osteogenic differentiation of BMMSCs, we examined expression levels of total β-catenin
and active β-catenin. We found that expression of β-catenin and active β-catenin was
decreased in both CBS+/− and H2S inhibitor-treated BMMSCs (Figure 7D). Moreover, when
TOPflash and its control FOPflash were transfected to normal and CBS+/− BMMSCs,
comparing the relative levels of luciferase activity confirmed that the canonical Wnt/βcatenin pathway was inhibited in CBS+/− BMMSCs (Figure 7E). Reduced β-catenin levels in
both CBS+/− BMMSCs and H2S inhibitor-treated BMMSCs were rescued by H2S donor
NaHS treatment, again as assessed by relative luciferase activity (Figure 7F). Interestingly,
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PKC inhibitor treatment blocked NaHS-rescued β-catenin expression in both CBS+/− and
H2S inhibitor-treated BMMSCs (Figure 7G), suggesting that the PCK pathway may regulate
β-catenin expression under CBS-deficient conditions. Additionally, we showed that PKC
activator and ErK inhibitor treatment rescued the osteogenic deficiency in CBS+/− and H2S
inhibitor-treated BMMSCs, as assessed by alizarin red staining, Western blot analysis, and
in vivo BMMSC implantation (Figures 7H–7J, Figure S7B). These data confirm that PCK
and Erk pathways contribute to H2S deficiency-associated osteogenesis. Moreover,
combinative knockdown of sulfhydration-associated of Ca2+ channels TRPV6, TRPV3, and
TRPM4, which reduced NaHS-induced Ca2+ influx (Figure 6C), also resulted in
upregulation of P-Erk, along with downregulation of p-PKC and active-β-catenin (Figure
7K). Moreover, combinative knockdown of TRPV6, TRPV3, and TRPM4 in BMSMCs by
siRNA resulted in reduced mineralized nodule formation and expression of osteocalcin and
Runx2 (Figures S7C and S7D). NaHS treatment failed to rescue altered expression of p-Erk,
p-PKC, and active-β-catenin, as assessed by Western blot (Figure 7L) and also failed to
affect knockdown-induced mineralized nodule formation and expression of osteocalcin and
Runx2 (Figures S7C and S7D), indicating that H2S-induced Ca2+ influx in BMMSCs was
regulated by multiple Ca2+channels, at least including TRPV6, TRPV3, and TRPM4, via a
sulfhydration manner.

DISCUSSION
Reduction of H2S levels contributes to osteopenia phenotype in CBS-deficient mice
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Classic clinical features of untreated CBS-deficient patients include a variety of phenotypes,
including myopia, ectopialentis, mental retardation, thromboembolic disorders, and
osteoporosis. Osteoporosis is characterized by low bone mass and deterioration of osseous
microarchitecture, resulting in decreased bone strength and increased risk of fragility
fractures. This phenotypeis often observed in patients with hyperhomocysteinemia
(Herrmann et al., 2005; Melton, 2003). Cell culture studies have suggested that high
homocysteine (HCY) levels may stimulate osteoclast activity (Herrmann et al., 2005; Koh et
al., 2006). Our data showed that osteoclast activity was significantly increased in CBS
deficient mice, in which both HCY and RANKL may enhance osteoclast activity. The effect
of high HCY levels on osteoblasts is controversial. Increased concentrations of HCY may
enhance cell apoptosis through activation of the NF-κB pathway and impair osteogenic
differentiation in osteoblast cell line HS-5 (Koh et al., 2006). Other reports showed that
increased concentrations of HCY stimulate primary human osteoblast differentiation
(Herrmann et al., 2007; Herrmann et al., 2008) and may not damage the osteogenic function
of preosteoblastic cells (Carmel et al., 1988; Sakamoto et al., 2005; Thaler et al., 2010). In
this study, we found that HCY treatment failed to induce BMMSC impairment. Although
CBS−/− mice showed an increase in serum HCY level to about 34 times that of controls,
while the level in CBS+/− mice only doubled, both CBS−/− and CBS+/− BMMSCs showed a
marked impairment of osteogenic differentiation, along with an osteopenia phenotype.
Therefore, we hypothesize that BMMSC impairment, which may not be related to the high
level of HCY, also contributes to the osteopenia phenotype observed in CBS-deficient mice.
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In addition to the elevated levels of HCY, a CBS-deficient condition results in a reduction in
the H2S level. However, it was unknown whether this reduced H2S level contributes to the
osteopenia phenotype. In this study, we revealed that elevating H2S levels in CBS+/− mice
by H2S donor GYY4317 treatment rescued the osteopenia phenotype, but failed to
significantly alter the HCY level. In addition, CBS inhibitor treatment failed to significantly
elevate the HCY level, but did result in an osteopenia phenotype like the one observed in
CBS+/− mice, with marked impairment of BMMSCs. Although intraperitoneal injection of
CBS inhibitor HA only partially reduced the expression level of CBS, the same as observed
in CBS+/− mice, the HA treatment was capable of significant reducing the levels of H2S.
These data suggest that partial deficiency of CBS expression is capable of reducing H2S
levels, resulting in an osteopenia phenotype. The reduction of H2S levels in the bone
microenvironment plays a critical role in CBS deficiency-associated osteopenia, perhaps
through regulation of BMMSC functions.
H2S regulatesCa2+ influx via sulfhydration of TRP channels in BMMSCs
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H2S-induced Ca2+ influx was diminished in CBS-deficient BMMSCs and CBS inhibitortreated BMMSCs, suggesting that the H2S, at the physiological level, plays a critical role in
maintaining normal function of the Ca2+ channels in BMMSCs. The mechanism underlying
H2S control of different Ca2+ channels is unknown. Interestingly, when the number of
sulfhydryl groups on TRP channels was altered by DTT and DM treatment, H2S-induced
Ca2+ influx was significantly affected. These data suggest that the number of sulfhydryl
groups in Cys of multiple TRP channels may regulate H2S-mediated Ca2+ influx.
The unique function of a gasotransmitter, which differs from classical signaling molecules in
the body, lies in its ability to permeate membranes freely and to target specific molecules
easily. It has been widely accepted that a single ligand usually reacts with one special Ca2+
channel. Here, we suggest that a physiological level of H2S maintains the sulfhydryl levels
in order to ensure normal Ca2+ channel function. In the process of sulfhydration, the
sulfhydryl group of a reactive Cys is modified to an -SSH group, resulting in increased
reactivity of the Cys residue.
Conclusion
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The functional role of H2S in different tissues is still not fully elucidated. Our study
indicates that physiological levels of H2S are required to maintain intercellular Ca2+
homeostasis by sulfhydration of multiple TRP channels in BMMSCs. Reduction of H2S
levels results in a cascade response in BMMSCs, including altered Ca2+ channel
sulfhydration, Ca2+ influx, Wnt/β-catenin signaling, and osteogenic differentiation. The
eventual result is an osteoporosis phenotype. It is anticipated that advances in understanding
the role of H2S may lead to H2S donor-based therapeutic approaches for H2S deficiencyrelated disorders (Mancardi et al., 2009).
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Animals
Female C57BL/6J and 129P2-Cbstm1Unc/J mice were purchased from the Jackson Lab (Bar
Harbor, ME). Female immunocompromised mice (Beige nude/nude XIDIII) were purchased
from Harlan (Indianapolis, IN). All animal experiments were performed under institutionally
approved protocols for the use of animal research (University of Southern California
protocols #10874 and 10941).
Isolation of mouse bone marrow mesenchymal stem cells (BMMSCs)
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Bone marrow cells were flushed out from the bone cavities of femurs and tibias with 2%
heat-inactivated fetal bovine serum (FBS; Equitech-Bio, Kerrville, TX) in PBS. Single-cell
suspension of all nuclear cells (ANCs) was obtained by passing through 70 μm cell strainer
(BD Bioscience, Franklin Lakes, NJ). All nuclear cells were seeded at 15×106 into 100 mm
culture dishes (Corning Corporation) and initially incubated for 48 hours at 37 °C in 5%
CO2. To eliminate the nonadherent cells, the cultures were washed with PBS twice. The
attached cells were cultured for 16 days. The BMMSCs were cultured with alpha minimum
essential medium (Alpha-MEM, Invitrogen Corporation, Carlsbad, CA) supplemented with
20% FBS, 2 mM L-glutamine (Invitrogen Corporation), 55 μM 2-mercaptoethanol
(Invitrogen Corporation), 100 U/ml penicillin, and 100 μg/ml streptomycin (Invitrogen
Corporation).
Injection of H2S donor and inhibitor into mice
H2S donor NaHS and GYY4317, CBS inhibitor HA, and CSE inhibitor PAG were
intraperitoneally injected into mice, as described in Table S2. One month later, the samples
were harvested, and further experiments were carried out.
Cytoimmunofluorescent microscopy
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The cells were subcultured on 8-well chamber slides (Nunc) (2×103/well) under the culture
medium for 12 hours at 37°C in 5% CO2. Then the samples were fixed in 4%
parafomaldehyde, followed by 0.01% Triton-100 treatment for 10 min. The samples were
blocked with normal serum matched to secondary antibodies and incubated with specific
orisotype-matched mouse antibodies (1:200) overnight at 4 °C. The samples were treated
with Rhodamine/FITC-conjugated secondary antibodies (1:200, Jackson ImmunoResearch,
West Grove, PA; Southern Biotechnology, Birmingham, AL) and were mounted by means
of a vectashield mounting medium containing 4′, 6-diamidino-2-phenylindole (DAPI)
(Vector Laboratories, Burlingame, CA).
Sulfhydryl groups measured by Ellman’s test
Ellman’s Reagent (5,5′-dithio-bis-[2-nitrobenzoic acid] DTNB) is used to quantitate free
(reduced) sulfhydryl groups (–SH) by comparing to a standard curve of a sulfhydrylcontaining compound, such as cysteine. Alternatively, sulfhydryl groups can be assayed
using the extinction coefficient of TNB (14,150 M−1 cm−1 at 412 nm). Ellman’s Reagent has
provided a reliable method to measure reduced cysteines and other free sulfhydryls in
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solution. DTNB reacted with a free sulfhydryl group to yield a mixed disulfide and 2nitro-5-thiobenzoic acid (TNB). The target of DTNB in this reaction is the conjugate base (R
—S-) of a free sulfhydryl group. Briefly, 4 mg DTNB was dissolved in 1 ml reaction buffer
(0.1 M sodium phosphate, pH 8.0, containing 1 mM EDTA). A set of test tubes was
prepared, each containing 50 μl of Ellman’s reagent solution and 2.5 ml of reaction buffer.
To analyze the sulfhydryl groups in living cells, 500 μl of Ellman’s reagent solution was
directly added into each well of the culture plate, mixed and incubated at room temperature
for 15 minutes. Then the solution was collected and absorbance measured at 412 nm.
Cysteine hydrochloride monohydrate was used as a reference standard.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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•

H2S produced by mesenchymal stem cells (MSCs) regulates their osteogenic
potential

•

Loss of H2S signaling causes osteoporotic phenotypes in mice

•

H2S deficiency reduces Ca2+ flux and sulfhydration of TRP Ca2+ channels

•

Reduced intracellular Ca2+ flux reduces β-catenin activity via a PKC/Erk
pathway
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Figure 1. BMMSCs produced H2S

(A, B) Both human (h) and mouse (m) BMMSCs express CBS and CSE, as assessed by
Western blotting (A) and RT-PCR (B). (C) Immunocytochemical staining confirmed that
both human and mouse BMMSCs expressed CBS and CSE. (D, E) Double immunostaining
(D) and flow cytometric analysis (E) showed that 30% of CBS-positive and 23% of CSEpositive mouse BMMSCs expressed mesenchymal stem cell marker CD73. (F) Mouse
BMMSC culture supernatant contained around 20 μM H2S. H2S levels were immediately
upregulated by H2S donor NaHS (100 μM) treatment and downregulated by CBS inhibitor
hydroxylamine (HA, 100 μM) or CSE inhibitor D, L-propargylglycine (PAG, 100 μM)
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treatment for 24 hours. When same amount of HA and PAG were added to the culture, the
reduction of H2S levels were the same as HA and PAG group. (G) The normal H2S level in
C57BL6 mouse serum is about 16.2 μM. H2S levels were immediately elevated upon IP
injection of H2S donor NaHS and reduced by IP injection of CBS inhibitor HA or CSE
inhibitor PAG treatment for 24 hours. Combinative IP injection of the same amount of HA
and PAG showed the same levels of H2S reduction as observed in HA and PAG group. *
P<0.05, ** P< 0.01, scale bar: 50 μm. Experiments were repeated three times. See also
Figure S1.
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Figure 2. H2S-deficient mice showed osteopenia phenotype and BMMSC impairment
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(A) Serum H2S levels decreased by almost half in CBS+/− mice compared with control
C57BL6 mice (WT). Although serum H2S levels in CBS−/− mice were lower than in CBS+/−
mice, no significant difference was observed between CBS+/− and CBS−/− mice. (B) H2S
levels in the culture supernatant of CBS+/− and CBS−/− BMMSCs showed a reduction to half
that of the normal BMMSC group (WT). No cell: background control. (C) Femur trabecular
bone volume in 66.6% of CBS+/− mice and all CBS−/− mice was significantly reduced
(yellow square) in comparison to C57BL6 mice (WT), as evaluated by H&E staining
analysis. (D) Osteopenia phenotype was confirmed in CBS+/− and CBS−/− mice by
microQCT analysis. CBS+/− and CBS−/− mice showed significantly reduced bone mineral
density (BMD) and bone volume/tissue volume (BV/TV) compared to C57BL6 mice (WT).
(E) BrdU labeling assay showed that CBS+/− and CBS−/− BMMSCs had increased
proliferation rates when compared to normal BMMSCs (WT). (F) When cultured under
osteogenic inductive conditions, CBS+/− and CBS−/− BMMSCs showed reduced capacities
to form mineralized nodules (evaluated by alizarin red staining) and express osteogenic
markers Runx2 and ALP (evaluated by Western blotting). (G) When BMMSCs were
subcutaneously implanted into immunocompromised mice using hydroxyapatite tricalcium
phosphate (HA/TCP; HA) as a carrier, new bone regeneration was reduced in CBS+/− and
CBS−/− BMMSC implants compared to normal BMMSC implants (WT). CT: connective
tissue. *P<0.05, **P< 0.01, scale bar: 1000 μm (C), 200 μm (G). Experiments were
repeated three times. See also Figure S2.
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Figure 3. H2S levels affected BMMSC function in vitro
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(A, B) H2S donor NaHS (100 μM) treatment for 24 hours rescued impaired CBS+/−
BMMSCs (CBS+/−) function, as indicated by reduction of proliferation rate evaluated by
BrdU staining (A) and elevation of mineralized nodule formation evaluated by alizarin red
staining, and increased expression of osteogenic marker Runx2 and ALP evaluated by
Western blotting (B). (C) When implanted into immunocompromised mice subcutaneously
using HA/TCP (HA) as a carrier, NaHS-treated CBS+/− BMMSCs (CBS+/− +NaHS) showed
improved capacity to generate new bone and bone marrow (BM). Normal BMMSCs were
used as a control. (D–F) Moreover, we showed that blockage of H2S levels by CBS inhibitor
(HA, 100 μM), CSE inhibitor (PAG, 100 μM), CBS siRNA, and CSE siRNA treatment for
24 hours resulted in increased proliferation rate as evaluated by BrdU staining (D), but
reduced mineralized nodule formation as shown by alizarin red staining, and reduced
expression of osteogenic markers Runx2 and ALP as shown by Western blotting (E).
Normal BMMSCs were used as a control. (F) When implanted into immunocompromised
mice subcutaneously using HA/TCP (HA) as a carrier, BMMSCs treated by HA, PAG, CBS
siRNA, or CSE siRNA showed reduction in the capacity to generate new bone in vivo. CT:
connective tissue. * P<0.05, ** P< 0.01, scale bar: 200 μm. Experiments were repeated three
times. See also Figure S3.
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Figure 4. Intraperitoneal injection of H2S donor GYY4317 rescued osteopenia phenotype and
BMMSC function in CBS+/− mice
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(A) H2S donor GYY4317 was IP injected to CBS+/− mice every other day at 1 mg/mouse for
28 days (total 14 times). After the last injection, the samples were harvested for further
experiments. (B–D) After GYY4317 treatment, CBS+/− mice showed significantly increased
serum H2S levels (B), femur trabecular bone volume as shown by H&E staining (C), bone
mineral density (BMD) and bone volume/tissue volume (BV/TV) as shown by microQCT
(D). Wildtype mice were used as control (WT). (E–G) When compared with CBS+/−
BMMSCs (CBS+/−), BMMSCs from GYY4317-treated CBS+/− mice (CBS+/− +GYY4317)
showed reduced proliferation as evaluated by BrdU labeling (E), elevated mineralized
nodule formation shown by alizarin red staining, elevated expression of ostegenic markers
Runx2 and ALP (F), and increased new bone formation when implanted into
immunocompromised mice subcutaneously using HA/TCP as a carrier (HA). CT: connective
tissue (G). Wildtype mice were used as control (WT). * P<0.05, ** P< 0.01, scale bar: 1000
μm (C), 200 μm (H). Experiments were repeated three times. See also Figure S4.
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Figure 5. Intraperitoneal injection of CBS inhibitor induced osteopenia phenotype and BMMSC
impairment
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(A) CBS inhibitor HA was IP injected to C57BL6 mice every other day at 100 μg/mouse for
28 days (totally 14 times injection), and after that BMMSCs were isolated. (B, C) HA
injection resulted in significantly reduced levels of H2S (B) and expression of CBS, as
assessed by Western blotting (C). (D, E) HA injection induced marked reduction in mouse
femur trabecular bone volume as assessed by H&E staining (D) and bone mineral density
(BMD), as well as bone volume/tissue volume (BV/TV), as assessed by microQCT analysis
(E). (F, G) BMMSCs derived from HA-treated mice showed increased proliferation rates, as
assessed by BrdU labeling (F) and increased mineralized nodule formation as shown by
alizarin red staining and increased expression of osteogenic markers Runx2 and ALP as
shown by Western blotting (G). (H) BMMSCs from HA-treated mice showed decreased
capacity to generate new bone when implanted into immunocompromised mice
subcutaneously using HA/TCP (HA) as a carrier. BM: bone marrow; CT: connective tissue.
(I) BMMSCs from HA-treated mice showed no change in the number of Oil red O-positive
cells or expression of LPL and PPARγ2 when compared to untreated control group. *
P<0.05, ** P< 0.01, scale bar: 1000 μm (D), 200 μm (I). Experiments were repeated three
times. See also Figure S5.
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Figure 6. H2S regulated Ca2+ influx via sulfhydration of Ca2+ channels
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(A) Ca2+ levels were measured from the ratio of emission in response to excitation at 340
nm and 380 nm by microscopy. H2S donor NaHS (10 μM to 10 mM) induced a dosedependent Ca2+ influx in BMMSCs. Arrows represent the time points when H2S donor
NaHS was added. (B) When 100 μM NaHS, with or without 1 mM CaCl2, was used to treat
BMMSCs, Ca2+ flux only occurred in the presence of CaCl2, indicating that the calcium
influx mainly came from outside the cell membrane, but not from the endoplasmic reticulum
or mitochondria. (C) When combination knockdown of TRPV6, TRPV3, and TRPM4
expression was induced in BMMSCs by siRNA, NaHS-induced Ca2+ flux was significantly
reduced. (D) Ellman’s test showed that sulfhydryl numbers on the cytomembrane were
decreased in CBS+/− BMMSCs when compared to normal BMMSCs. (E) Statistical analysis
showed that 1 mM DTT treatment significantly elevated NaHS-induced Ca2+ influx, but 1
mM DM or MTSES significantly reduced NaHS-induced Ca2+ influx when compared to the
control group (100 μM NaHS treatment). DM treatment exhibited more effective inhibition
of Ca2+ influx than MTSES. (F) Ellman’s test showed DTT treatment increased the number
of free sulfhydryls in BMMSCs, while DM decreased the number of free sulfhydryls in
BMMSCs. MTSES also reduced the sulfhydryl number in the BMMSC membrane. (G)
Protein sulfhydration in BMMSCs, with or without NaHS treatment, was assessed by Alexa
Fluor 488-conjugated C5 maleimide. (H) After 1 mM DTT treatment, sulfhydration of
TRPV6 protein was calculated based on residual green fluorescence intensity in comparison
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to total level of TRPV6 protein. Without NaHS treatment, DTT failed to affect the levels of
“green” TRPV6 protein, indicating the absence of sulfhydration. In contrast, NaHS
treatment reduced the green signal of TRPV6 protein in the presence of DTT, indicating that
sulfhydration occurred. * P<0.05, ** P< 0.01. Experiments were repeated three times. See
also Figure S6.
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Figure 7. H2S-deficiency downregulated Wnt/β-catenin pathway via reduced Ca2+ influx in
BMMSCs
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(A) CBS+/− and H2S inhibitor HA (100 μM)-treated BMMSCs cultured for 24, 48, or 72
hours showed significant downregulation of p-PKC and upregulation of p-Erk. In contrast,
H2S donor NaHS (100 μM) treatment for 5, 30, or 60 minutes upregulated p-PKC and
downregulated p-Erk in BMMSCs. (B) When pretreated with 2APB (10 μM) and
SKF-96365 (10 μM) for 15 min to block Ca2+ influx, NaHS treatment failed to upregulate pPKC expression in BMMSCs. (C) Erk inhibitor (PD325901 1 μM) treatment failed to affect
p-PKC expression in BMMSCs, indicating that Erk might be the downstream the PKC
signaling. (D) When CBS inhibitor HA (100 μM) or CSE inhibitor PAG (100 μM) was used
to reduce H2S levels, BMMSCs showed significant reduction in total β-catenin and active βcatenin expression at 3 days post-treatment. (E) When TOPflash and control FOPflash were
transfected into normal and CBS+/− BMMSCs, luciferase activity indicated that the
canonical Wnt/β-catenin pathway was inhibited in CBS+/− BMMSCs in comparison to
normal BMMSCs. (F) Reduced β-catenin expression in both CBS+/− and H2S inhibitor HA
(100 μM)-treated BMMSCs was rescued by H2S donor NaHS (100 μM) treatment, as
assessed by luciferase activity. (G) Rescue of β-catenin expression by NaHS (100 μM) in
both CBS+/− and HA (100 μM)-treated BMMSCs was blocked by PKC inhibitor (Gö 6976,
10 nM) treatment, as assessed by luciferase activity. (H, I) PKC activator and Erk inhibitor
treatment rescued the osteogenic deficiency in both CBS+/− and HA-treated BMMSCs, as
assessed by alizarin red staining to show mineral nodule formation. (J) In vivo BMMSC
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implantation showed that PKC activator and Erk inhibitor treatment rescued CBS+/−
BMMSC-mediated new bone formation. HA: HA/TCP; BM: bone marrow; CT: connective
tissue. (K) Western blotting showed that combinative knockdown of TRPV6, TRPV3, and
TRPM4 channels by siRNA led to upregulation of p-Erk and downregulation of p-PKC,
active-β-catenin and β-catenin. (L) H2S donor NaHS treatment failed to rescue the altered
expression of p-Erk, p-PKC, active-β-catenin and β-catenin, as assessed by Western blotting.
* P<0.05, ** P< 0.01. Experiments were repeated three times. See also Figure S7.
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